Acurx Pharmaceuticals, Inc. (ACXP)
1.43
+0.01
(+0.70%)
USD |
NASDAQ |
Sep 08, 16:00
1.435
0.00 (0.00%)
Pre-Market: 20:00
Acurx Pharmaceuticals Total Assets (Quarterly) : 10.98M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.98M |
| March 31, 2026 | 9.54M |
| December 31, 2025 | 7.690M |
| September 30, 2025 | 6.105M |
| June 30, 2025 | 6.158M |
| March 31, 2025 | 4.806M |
| December 31, 2024 | 3.858M |
| September 30, 2024 | 5.983M |
| June 30, 2024 | 6.580M |
| March 31, 2024 | 9.109M |
| December 31, 2023 | 7.709M |
| Date | Value |
|---|---|
| September 30, 2023 | 7.158M |
| June 30, 2023 | 9.236M |
| March 31, 2023 | 7.385M |
| December 31, 2022 | 9.377M |
| September 30, 2022 | 10.95M |
| June 30, 2022 | 9.259M |
| March 31, 2022 | 11.32M |
| December 31, 2021 | 13.25M |
| September 30, 2021 | 14.99M |
| June 30, 2021 | 17.44M |
| March 31, 2021 | 2.982M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.833M |
| Shareholders Equity (Quarterly) | 8.152M |
| Current Ratio | 3.878 |